undefined

undefined

Home page

Jiudian Hongyang's API Trimebutine Maleate Approved for Marketing

Jiudian Hongyang's API Trimebutine Maleate Approved for Marketing

At the beginning of Feb 2025, Jiudian Hongyang's API trimebutine maleate (Y20230000418) officially received the marketing approval from the CDE, and its registration status was successfully changed to "A".

10

2025

/

02

Jiudian Pharmaceutical Research Institute successfully completed the annual laboratory instrument maintenance and cleaning

Jiudian Pharmaceutical Research Institute successfully completed the annual laboratory instrument maintenance and cleaning

On January 24, under the meticulous planning and coordination of the Quality Control Department of the Drug Research Institute, the annual instrument maintenance and cleaning of the R&D laboratory were successfully completed. The crucial task ensures the efficient and stable operation of laboratory instruments and equipment in the upcoming year, providing robust support for drug research and development.

26

2025

/

01

Jiudian Hongyang's pharmaceutical excipients Succinic acid and Calcium hydrogen phosphate dihydrate approved for marketing

Jiudian Hongyang's pharmaceutical excipients Succinic acid and Calcium hydrogen phosphate dihydrate approved for marketing

Recently, Jiudian Hongyang's pharmaceutical excipients succinic acid (F20220000468) and calcium hydrogen phosphate dihydrate (F20220000396) have officially obtained marketing approval from the Center for Drug Evaluation (CDE), and the registration status of these products has been successfully updated to "A".

25

2025

/

01

Jiudian Pharmaceuticals held the 2024 Annual Summary and Commendation and 2025 Spring Festival Gala

Jiudian Pharmaceuticals held the 2024 Annual Summary and Commendation and 2025 Spring Festival Gala

On the afternoon of January 24, with the theme"Gathering wisdom to control changes, drawing new pictures to win the future"-Jiudian Pharmaceutical's 2024 Annual Summary and Commendation, as well as the 2025 Spring Festival Gala， was grandly held in Changsha. All employees of the company gathered to review the efforts of the past year, share the joy of success, gather wisdom, and look forward to the future.

25

2025

/

01

Jiudian Hongyang's API Benidipine successfully passed drug registration on-site

Jiudian Hongyang's API Benidipine successfully passed drug registration on-site

From January 14 to 17, Jiudian Hongyang welcomed the on-site inspection for the registration of the API benidipine hydrochloride. The inspectors fully affirmed Jiudian Hongyang's production quality management and Jiudian Research Institute's research quality, announcing that the inspection was successfully passed.

22

2025

/

01

Jiudian Pharmaceutical successfully passed the official inspection of Hainan and Beijing Food and Drug Administration

Jiudian Pharmaceutical successfully passed the official inspection of Hainan and Beijing Food and Drug Administration

From January 7 to January 9, Jiudian Pharmaceuticals welcomed two official inspections. The Hainan Provincial Drug Administration dispatched three inspectors to conduct a three-day GMP compliance inspection of Jiudian Production Center. At the same time, the Beijing Municipal Drug Administration also dispatched two inspectors to visit our company for an on-site inspection of the change of production site of clarithromycin granules.

13

2025

/

01

Jiudian Pharmaceutical's Dapagliflozin Tablets Approved for Marketing

Jiudian Pharmaceutical's Dapagliflozin Tablets Approved for Marketing

At the beginning of 2025, after review by the Drug Evaluation Center of the NMPA, Jiudian Pharmaceutical's dapagliflozin tablets were approved for marketing. Jiudian® dapagliflozin tablets had successfully broken through the patent barriers of the original crystal form before they were launched, and passed the consistency evaluation, ensuring the safety and effectiveness of the drug, which can reduce the medication burden for diabetic patients and improve the accessibility of diabetic patients.

06

2025

/

01

Jiudian Pharmaceutical successfully passed the special dietary food license inspection

Jiudian Pharmaceutical successfully passed the special dietary food license inspection

On January 3, the Hunan Provincial Market Supervision Administration dispatched 3 experts and 1 observer to conduct on-site inspections on the expansion of the production license of sports nutrition food of Jiudian Pharmaceutical in accordance with the "Food Production License Management Measures", "General Rules for Food Production License Review" and "Food and Food Additive Production License On-site Verification Scoring Record Form".

06

2025

/

01

< 1 2 3 4...9 >

Bldg A1, Wukuang Lugu Science and Technology Industry Park, No.28 Lutian Road, Hi-tech development zone, Changsha, Hunan, China TEL. 0086-731-88220222

1

Business license

SEO www.300.cn changsha Privacy policy